Mutual of America Capital Management’s Palvella Therapeutics PVLA Stock Holding History

Mutual of America Capital Management’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.79M	Buy	+31,318	New	+$3.8M	0.05%	455

Other funds holding PVLA

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

CAM

Clio Asset Management Charlottesville, Virginia $126M AUM 16.01% 1-Year Est. Return

LCG

Lisanti Capital Growth New York $455M AUM 218.66% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return

Mutual of America Capital Management's PVLA Position: Q2 2026 in Review

Mutual of America Capital Management opened a new position in Palvella Therapeutics (PVLA) in Q2 2026: 31,318 shares worth $4.79M. The stake represents 0.05% of the portfolio and ranks #455 among its holdings.

85 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

Mutual of America Capital Management held 31,318 shares of Palvella Therapeutics worth $4.79M as of Q2 2026.
Palvella Therapeutics was a new Mutual of America Capital Management position in Q2 2026.
Palvella Therapeutics made up 0.05% of Mutual of America Capital Management's portfolio in Q2 2026, its #455 holding.
85 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.